Recent Company News

• 11:59 AM ET Aug 17, 2026
  

  StreetAccount Summary - U.S. Unusual Option Volume: VIX +4.9% to 14.95; S&P 500 (0.1%) to 7,775.64

• 08:53 AM ET Aug 12, 2026
  

  StreetAccount Summary - US Initial Syndicate recap for 12-Aug

• 08:18 AM ET Aug 12, 2026
  

  StreetAccount Summary - US Pre-market trading

• 11:23 PM ET Aug 11, 2026
  

  Silence Therapeutics 13.0M-ADS secondary priced at $13.50/ADS ($14.72, 0.00)

• 10:12 PM ET Aug 11, 2026
  

  Silence Therapeutics files to increase size of ADS offering by $40.0M - S-3MEF ($14.72, 0.00)

• 02:29 PM ET Aug 11, 2026
  

  StreetAccount Summary - US equity offerings expected to price for Wednesday, 12-Aug

• 09:18 AM ET Aug 11, 2026
  

  StreetAccount Summary - US Pre-market trading update

• 05:00 PM ET Aug 10, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 04:04 PM ET Aug 10, 2026
  

  Silence Therapeutics to offer $150M of American Depositary Shares ($15.43, 0.00)

• 10:03 AM ET Aug 10, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (108 total)